Ascorbic acid (high-dose)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Ascorbic acid (high-dose), covering 2013-03-06 to 2026-04-09. Get the full timeline:
Most recent: Clinical Trial Update: High-dose Ascorbate (HDA) in Combination With Standard of Care Azacitidine and Venetoclax in Acute Myeloid Leukemia (AML) [Phase 1]